nadp has been researched along with Granulocytic Leukemia, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catanzano, F; Colavita, I; Esposito, N; Martinelli, R; Melo, JV; Pane, F; Ruoppolo, M; Salvatore, F | 1 |
| Boyd, MR; Monks, A; Pittman, A; Scudiero, D; Skehan, P; Vistica, DT | 1 |
| Hoffman, R; Jayaram, HN; Natsumeda, Y; Tricot, GJ; Weber, G; Yamada, Y; Yamaji, Y | 1 |
3 other study(ies) available for nadp and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Gaining insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: a comparative proteomic approach.
Topics: Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Blotting, Western; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Fusion Proteins, bcr-abl; Glutathione; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; NADP; Piperazines; Proteome; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured | 2010 |
Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.
Topics: Carcinoma, Renal Cell; Cell Division; Cell Line; Cell Survival; Coloring Agents; Drug Screening Assays, Antitumor; Formazans; Glucose; Humans; Kidney Neoplasms; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; NAD; NADP; Tetrazolium Salts; Thiazoles | 1991 |
IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
Topics: Adenine Nucleotides; Antineoplastic Agents; Blast Crisis; Female; Humans; IMP Dehydrogenase; Ketone Oxidoreductases; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; NADP; Ribavirin; Ribonucleosides | 1989 |